ATE166056T1 - Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents
Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthaltenInfo
- Publication number
- ATE166056T1 ATE166056T1 AT92916381T AT92916381T ATE166056T1 AT E166056 T1 ATE166056 T1 AT E166056T1 AT 92916381 T AT92916381 T AT 92916381T AT 92916381 T AT92916381 T AT 92916381T AT E166056 T1 ATE166056 T1 AT E166056T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- production
- pharmaceutical compositions
- compositions containing
- iii complexes
- Prior art date
Links
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052733 gallium Inorganic materials 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- CYFLXLSBHQBMFT-UHFFFAOYSA-N sulfamoxole Chemical group O1C(C)=C(C)N=C1NS(=O)(=O)C1=CC=C(N)C=C1 CYFLXLSBHQBMFT-UHFFFAOYSA-N 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91402093 | 1991-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE166056T1 true ATE166056T1 (de) | 1998-05-15 |
Family
ID=8208600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92916381T ATE166056T1 (de) | 1991-07-25 | 1992-07-23 | Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5525598A (de) |
| EP (1) | EP0599881B1 (de) |
| JP (1) | JP3480498B2 (de) |
| AT (1) | ATE166056T1 (de) |
| AU (1) | AU2360092A (de) |
| CA (1) | CA2114136C (de) |
| DE (1) | DE69225484T2 (de) |
| ES (1) | ES2120450T3 (de) |
| GR (1) | GR3027634T3 (de) |
| WO (1) | WO1993002087A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5852146A (en) * | 1996-06-27 | 1998-12-22 | Union Carbide Chemicals & Plastics Technology Corporation | Catalyst for the production of olefin polymers |
| US6203822B1 (en) * | 1996-09-03 | 2001-03-20 | University Of Iowa Research Foundation | Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infection |
| JP2003510362A (ja) * | 1999-10-04 | 2003-03-18 | ローレンス・アール・バーンスタイン | 細胞内原核生物、dnaウイルス及びレトロウイルスによる感染を治療するための、3−ヒドロキシ−4−ピロンのガリウム錯体 |
| US20020160055A1 (en) * | 2000-09-18 | 2002-10-31 | Jack Stapleton | Methods for treating human immunodeficiency virus infections with gallium compositions |
| DE10113185A1 (de) * | 2001-03-19 | 2002-10-24 | Faustus Forschungs Cie | Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex |
| DE10116527C2 (de) * | 2001-04-03 | 2003-05-15 | Faustus Forschungs Cie | Tumorhemmende Galliumverbindungen, deren Verwendung als Arzneimittel sowie ein Arzneimittel, diese enthaltend |
| CA2550119A1 (en) * | 2003-12-17 | 2005-06-30 | Titan Pharmaceuticals, Inc. | Use of gallium to treat inflammatory arthritis |
| AU2005321803B2 (en) | 2004-12-29 | 2012-02-09 | Emisphere Technologies, Inc. | Pharmaceutical formulations of gallium salts |
| AT501262B8 (de) * | 2005-01-24 | 2007-02-15 | Faustus Forschung Translationa | Verwendung von gallium(iii)-komplexen zur behandlung von tumoren des urothelialtraktes |
| AT501819B1 (de) * | 2005-04-18 | 2007-01-15 | Faustus Forschung Translationa | Verwendung von gallium(iii)-komplexen zur behandlung von tumorerkrankungen der leber |
| WO2007100382A2 (en) * | 2005-10-27 | 2007-09-07 | Bernstein Lawrence R | Orally administrable gallium compositions and method of use |
| CA2626029A1 (en) | 2005-11-04 | 2007-05-18 | Genta Incorporated | Pharmaceutical gallium compositions and methods |
| US20070231406A1 (en) * | 2006-01-30 | 2007-10-04 | Bucalo Louis R | Use of gallium to treat biofilm-associated infections |
| AT503317B1 (de) * | 2006-02-13 | 2007-09-15 | Faustus Forschung Translationa | Verwendung von gallium(iii)-komplexen zur herstellung eines medikaments zur behandlung von melanomen |
| US9364502B2 (en) * | 2006-06-28 | 2016-06-14 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
| US8168214B2 (en) * | 2006-11-09 | 2012-05-01 | Bernstein Lawrence R | Local administration of gallium compositions to treat pain |
| CN102665421A (zh) * | 2009-03-30 | 2012-09-12 | 尼基制药公司 | 治疗骨质疏松的方法 |
| KR101783676B1 (ko) * | 2010-02-12 | 2017-10-10 | 니키 파머 액퀴지션 코포레이션 2 | 혈액암의 치료 방법 |
| CN103108636A (zh) * | 2010-02-26 | 2013-05-15 | 尼基制药公司 | 治疗脑癌的方法 |
| JP5801378B2 (ja) * | 2010-04-19 | 2015-10-28 | ニーキ ファーマ インコーポレイテッド | プロテアソーム阻害剤およびガリウム錯体を用いた併用療法 |
| CA2831206A1 (en) * | 2010-04-23 | 2011-10-27 | Niiki Pharma Inc. | Method for treating pancreatic cancer |
| JP6112512B2 (ja) * | 2010-12-01 | 2017-04-12 | レクシ ファーマ インコーポレイテッド | 難治性癌を治療するための方法 |
| US20120245135A1 (en) * | 2011-03-24 | 2012-09-27 | Genta Incorporated | Gallium Complexes, Pharmaceutical Compositions And Methods Of Use |
| CN113372269A (zh) * | 2021-06-25 | 2021-09-10 | 云南大学 | 一种席夫碱镓配合物及其制备方法和应用 |
| CN115724863B (zh) * | 2022-10-10 | 2025-07-25 | 中国科学院合肥物质科学研究院 | 具有可调谐绿色荧光的氧化镓团簇及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4373223A (en) * | 1980-01-29 | 1983-02-15 | Mildoy Enterprises | Container opener |
| CA1219210A (en) * | 1982-10-22 | 1987-03-17 | Warrell Raymond P., Jr. | Use of gallium salts to treat disorders of calcium homeostasis |
| DE3240377A1 (de) * | 1982-11-02 | 1984-05-03 | Racek, Alfred, 1160 Wien | Feuerzeug |
-
1992
- 1992-07-23 ES ES92916381T patent/ES2120450T3/es not_active Expired - Lifetime
- 1992-07-23 US US08/178,241 patent/US5525598A/en not_active Expired - Lifetime
- 1992-07-23 AU AU23600/92A patent/AU2360092A/en not_active Abandoned
- 1992-07-23 WO PCT/EP1992/001687 patent/WO1993002087A1/en not_active Ceased
- 1992-07-23 JP JP50260693A patent/JP3480498B2/ja not_active Expired - Fee Related
- 1992-07-23 DE DE69225484T patent/DE69225484T2/de not_active Expired - Fee Related
- 1992-07-23 EP EP92916381A patent/EP0599881B1/de not_active Expired - Lifetime
- 1992-07-23 CA CA002114136A patent/CA2114136C/en not_active Expired - Lifetime
- 1992-07-23 AT AT92916381T patent/ATE166056T1/de not_active IP Right Cessation
-
1998
- 1998-08-12 GR GR980401812T patent/GR3027634T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2360092A (en) | 1993-02-23 |
| JPH07500575A (ja) | 1995-01-19 |
| EP0599881B1 (de) | 1998-05-13 |
| DE69225484T2 (de) | 1998-12-10 |
| GR3027634T3 (en) | 1998-11-30 |
| CA2114136A1 (en) | 1993-02-04 |
| US5525598A (en) | 1996-06-11 |
| JP3480498B2 (ja) | 2003-12-22 |
| EP0599881A1 (de) | 1994-06-08 |
| WO1993002087A1 (en) | 1993-02-04 |
| DE69225484D1 (de) | 1998-06-18 |
| CA2114136C (en) | 2003-07-29 |
| ES2120450T3 (es) | 1998-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE166056T1 (de) | Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| ATE113029T1 (de) | Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen. | |
| IL111077A (en) | Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
| DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
| HUT77925A (hu) | Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| EP0482410A3 (en) | Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation | |
| ZA948670B (en) | New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| HUT77627A (hu) | 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények | |
| ATE38988T1 (de) | Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| IL108571A0 (en) | Derivatives of quinolonecarboxylic acid and naphthyrdionecarboxylic acid, their preparation and pharmaceutical compositions containing them | |
| ATE107167T1 (de) | Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten. | |
| ATE153342T1 (de) | Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel | |
| NO972028D0 (no) | Kjemiske forbindelser og antikonsepsjonsmidler inneholdende disse | |
| DE3369983D1 (en) | Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| HUT77768A (hu) | N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk | |
| ES2017279A6 (es) | Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas. | |
| ATE43350T1 (de) | Nor-cholsaeure-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammenstellungen, die sie enthalten. | |
| GR3000773T3 (en) | 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them | |
| ATE144986T1 (de) | Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten | |
| ATE145647T1 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
| IL93748A0 (en) | Thienylacetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| ATE32063T1 (de) | Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung. | |
| KR900014372A (ko) | 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |